Brand Insights - Thought Leadership | Paid Program | Physicians Education Resource (PER)
Psychiatry Thought Leadership and Learning in Spotlight
Published: | Updated:
A closer look at the most impactful topics from the Annual Psychiatric Times World CME Conference.
Innovation for Impact – Interview with Phil Talamo
Published: | Updated:
When restrictions on travel and gatherings began to take effect due to the COVID-19 pandemic this past March, Physicians Education Resource®, LLC (PER®), was one of the first CME providers to fully embrace digital programming and quickly pivot to a digital landscape.
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: FDA Approves Hernexeos
2
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
FDA Approves Dupixent as First Treatment for Allergic Fungal Rhinosinusitis in Adults and Children
5